Relay Therapeutics, Inc. employees and revenue per employee

RLAY · Biotechnology · $3.56B market cap

Relay Therapeutics, Inc. had 192 employees at the end of fiscal Dec 2025, down 26.4% from a year earlier. Revenue for the year was $15.4M, up 53.4% from a year earlier, or $80K per employee. Revenue held up or grew while headcount stayed flat or fell.

Employees

192

-26.4% YoY

Revenue

$15.4M

+53.4% YoY

Revenue / employee

$80K

Peer median $457K

Rank in industry

94 of 110

Biotechnology

Open roles

15

78 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020
0111222'20'21'22'23'24'25Revenue 19Staff 121

Hover a year for the numbers.

RLAY employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025192$15.4M$80K-26.4%+53.4%
Dec 2024261$10.0M$38K-19.2%-60.8%
Dec 2023323$25.5M$79K-1.2%+1749.8%
Dec 2022327$1.4M$4K+33.5%-54.4%
Dec 2021245$3.0M$12K+54.1%-96.3%
Dec 2020159$82.7M$520K——

Open roles on its job board: 15 (78 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
159'20245'21327'22323'23261'24192'25
Revenue per employee, last six fiscal years
$520K'20$12K'21$4K'22$79K'23$38K'24$80K'25

Relay Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
CBIO
Crescent Biopharma, Inc.
44$10.8M$246K—
OABI
OmniAb, Inc.
89$18.7M$210KContracting
CAPR
Capricor Therapeutics, Inc.
160$22.3M$139KHiring into decline
ALMS
Alumis Inc.
221$24.1M$109K—
JANX
Janux Therapeutics, Inc.
109$10.0M$92KHiring into decline
RLAY
Relay Therapeutics, Inc.
192$15.4M$80KLeaner
PRAX
Praxis Precision Medicines, Inc.
116$8.6M$74KEfficient growth
PGEN
Precigen, Inc.
160$9.7M$61KEfficient growth
ZBIO
Zenas BioPharma, Inc.
167$10.0M$60KEfficient growth
Every Healthcare company

Questions about Relay Therapeutics, Inc.

How many employees does Relay Therapeutics, Inc. have?
Relay Therapeutics, Inc. reported 192 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 26, 2026. That is down 26.4% from a year earlier.
What is Relay Therapeutics, Inc.'s revenue per employee?
Relay Therapeutics, Inc. brought in $15.4M of revenue in fiscal Dec 2025, which is $80K per employee. That ranks 94 of 110 companies we track in Biotechnology, where the median is $457K.
Is Relay Therapeutics, Inc. hiring?
Relay Therapeutics, Inc.'s public job board listed 15 open roles on November 20, 2026, about 78 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare RLAY with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Relay Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 26, 2026. This is data, not a recommendation to buy or sell RLAY.